Author/Authors :
Akcay, Murat Department of Cardiology - Faculty of Medicine - Ondokuz Mayıs University - Samsun, Turkey
Abstract :
Saphenous vein grafts (SVGs) are widely used conduits for the surgical revascularization of coronary arteries, but they are
associated with poor long-term patency rates. Acute SVG thromboses often present as acute coronary syndrome and have
an extensive atherosclerotic and thrombotic burden. Percutaneous coronary intervention (PCI) is the first treatment option;
however, it carries a high risk of distal embolization, no-reflow, and periprocedural myocardial infarction. Reducing the
thrombus burden and preventing distal embolization during PCI can be achieved by using some pharmacological strategies
(e.g., glycoprotein IIb/IIIa antagonists) and devices (e.g., thrombectomy and filter devices). There are yet no better therapeutic
options for patients undergoing PCI of SVG occlusions. Here, we introduce a 52-year-old male patient admitted with a typical
acute chest pain of 1 hour’s duration. Electrocardiography showed signs of acute inferoposterior myocardial infarction. A
thrombotic SVG occlusion was detected in primary PCI, and a huge thrombus content was aspirated. After the thrombus
aspiration with stent implantation, the chest pain was relieved and the ST-segment elevation was improved. The patient has
been followed without any symptoms for 10 months.